haloperidol has been researched along with Adenocarcinoma, Basal Cell in 7 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The sigma receptor ligand reduced haloperidol (50 and 100 microM), potently inhibited cell proliferation, and induced apoptosis in WIDr colon and MCF-7 adenocarcinoma cell lines." | 7.69 | The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells. ( Brent, PJ; Dosen, PJ; Little, G; Pang, G; Van Helden, DF, 1996) |
| "Tamoxifen (TAM) has previously been shown to inhibit growth of the Dunning R3327 rat prostate adenocarcinoma and to elevate serum prolactin levels." | 7.67 | Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma. ( Ip, MM; Sylvester, PW, 1987) |
| "The sigma receptor ligand reduced haloperidol (50 and 100 microM), potently inhibited cell proliferation, and induced apoptosis in WIDr colon and MCF-7 adenocarcinoma cell lines." | 3.69 | The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells. ( Brent, PJ; Dosen, PJ; Little, G; Pang, G; Van Helden, DF, 1996) |
| "Tamoxifen (TAM) has previously been shown to inhibit growth of the Dunning R3327 rat prostate adenocarcinoma and to elevate serum prolactin levels." | 3.67 | Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma. ( Ip, MM; Sylvester, PW, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krakauer, EL | 1 |
| Zhu, AX | 1 |
| Bounds, BC | 1 |
| Sahani, D | 1 |
| McDonald, KR | 1 |
| Brachtel, EF | 1 |
| Vilner, BJ | 1 |
| John, CS | 1 |
| Bowen, WD | 1 |
| Brent, PJ | 1 |
| Pang, G | 1 |
| Little, G | 1 |
| Dosen, PJ | 1 |
| Van Helden, DF | 1 |
| Scholten-Sloof, BE | 1 |
| Knol, BW | 1 |
| Rijnberk, A | 1 |
| Mol, JA | 1 |
| Middleton, DJ | 1 |
| Ubbink, GJ | 1 |
| Iishi, H | 1 |
| Baba, M | 1 |
| Tatsuta, M | 1 |
| Okuda, S | 1 |
| Taniguchi, H | 1 |
| Sylvester, PW | 1 |
| Ip, MM | 1 |
| Devès, G | 1 |
| Ortega, R | 1 |
7 other studies available for haloperidol and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2005. A 58-year-old man with esophageal cancer and nausea, vomiting, and intractable hiccups.
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents, Hormonal; Barrett Esop | 2005 |
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Topics: Adenocarcinoma; Animals; Binding, Competitive; Breast Neoplasms; Carcinoma, Ductal, Breast; Glioblas | 1995 |
The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Bisbenzimidazole; Breast Neoplasms; Calcium; Cell Line; Chromatin; Coloni | 1996 |
Pituitary-dependent hyperadrenocorticism in a family of Dandie Dinmont terriers.
Topics: Adenocarcinoma; Adrenal Cortex; Adrenal Cortex Diseases; Animals; Corticotropin-Releasing Hormone; D | 1992 |
Inhibition by the dopamine antagonist haloperidol of experimental carcinogenesis induced by azoxymethane in rat colon.
Topics: Adenocarcinoma; Animals; Azoxymethane; Body Weight; Bromocriptine; Colonic Neoplasms; Cyclic AMP; DN | 1991 |
Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Topics: Adenocarcinoma; Animals; Bromocriptine; Cell Line; Drug Therapy, Combination; Haloperidol; Male; Neo | 1987 |
Subcellular mass determination by 4He+ energy-loss micro-spectrometry.
Topics: Adenocarcinoma; Epoxy Resins; Female; Helium; Humans; Microscopy, Electron, Scanning Transmission; O | 2002 |